Men and women concerned about maintaining healthy cholesterol levels can benefit from SupraBio Tocotrienols 200 mg, a dietary supplement created by Allergy Research Group. The tocotrienols contained in every SupraBio Tocotrienols 200 mg capsule is a formula developed by Allergy Research Group that has been extracted from fresh, virgin red palm oil. A process combining molecular distillation with extraction guarantees the purest tocotrienols for aiding the vascular system and promoting normal cholesterol levels.
By taking SupraBio Tocotrienols 200 mg by Allergy Research Group on a regular basis, individuals receive several important health benefits:
- Reduction in the amount of LDL, or bad, cholesterol.
- Assists in reversing blockages in the arteries.
- Assists in lowering buildup of cholesterol in the vascular system.
- Promotes a healthy cardiovascular system and greatly lowers the risk of cardiovascular disease.
- Offers antioxidant protection for the cells against damaging free radicals.
Suggested Use:
As a dietary supplement, 1 softgel two times daily, or as directed by a healthcare practitioner.
Serving size: 1 Softgel
Servings Per Container: 120
Amount Per Serving - Daily Value (%):
Tocomin SupraBio® 20% (non GMO) 1,315 mg**
containing:
Vitamin E (as 68 IU of d-Alpha Tocopherol )45.56 mg 304%
Natural d-Mixed Tocotrienols 200 mg**
d-Gamma-Tocotrienol
d-Alpha-Tocotrienol
d-Delta-Tocotrienol
d-Beta-Tocotrienol
Plant Squalene 13 mg**
Phytosterol Complex 13 mg**
**Daily Value not established
Other Ingredients:
Gelatin, glycerin, purified water, medium chain triglycerides, polyglycerol esters of fatty acids, mixed carotenoid complex, coenzyme Q10.
Warnings:
If you are pregnant, nursing, have a medical condition, or taking medications, consult your physician before using this product. Keep this product out of reach of children.
Store in a cool, dry place.
**These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
